FOUNDAYO
NDC 0002-4503, orforglipron, tablet, film coated, from Eli Lilly and Company.
- Product NDC
- 0002-4503
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220934
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ORFORGLIPRON CALCIUM2.5 mg/1
Pharmacologic classes
Decreased Gastric Motility [PE]; GLP-1 Receptor Agonist [EPC]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Increased Gastric Muscle Tone [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-4503-31 | 00002450331 | 1 BOTTLE in 1 CARTON (0002-4503-31) / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4503-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8ac446c5-feba-474f-a103-23facb9b5c62NADAC price for package 00002450331
GET /v1/drugs/nadac/00002450331
Use it
Look up 0002-4503 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-4503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.